About Sunbird Bio
Sunbird Bio is a company based in Singapore founded in 2020 by Carine Lim, Nicholas Ho, and Huilin Shao.. Sunbird Bio has raised $14 million across 1 funding round from investors including Lilly, EDBI and ClavystBio. Sunbird Bio has completed 1 acquisition, including Glympse Bio. Sunbird Bio offers products and services including APEX Test and ELISA Technology. Sunbird Bio operates in a competitive market with competitors including Guardant Health, Natera, Foundation Medicine, ArcherDX and Strand Life Sciences, among others.
- Headquarter Singapore
- Founders Carine Lim, Nicholas Ho, Huilin Shao
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sunbird Bio Pte. Ltd.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$14 M (USD)
in 1 rounds
-
Latest Funding Round
$14 M (USD), Series B
Oct 16, 2024
-
Investors
Lilly
& 4 more
-
Employee Count
Employee Count
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sunbird Bio
Sunbird Bio offers a comprehensive portfolio of products and services, including APEX Test and ELISA Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Blood test for detecting neurological disorders like Alzheimer's.
Sensor-based system for identifying disease proteins in blood.
Unlock access to complete
Unlock access to complete
Funding Insights of Sunbird Bio
Sunbird Bio has successfully raised a total of $14M through 1 strategic funding round. The most recent funding activity was a Series B round of $14 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series B — $14.0M
-
First Round
First Round
(16 Oct 2024)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2024 | Amount | Series B - Sunbird Bio | Valuation | Lilly , EDBI |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Sunbird Bio
Sunbird Bio has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Lilly, EDBI and ClavystBio. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government-backed investments are directed toward healthcare, fintech, and various sectors.
|
Founded Year | Domain | Location | |
|
US focused venture capital firm
|
Founded Year | Domain | Location | |
|
Tech startups are funded by S32, a venture capital entity.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sunbird Bio
Sunbird Bio has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Glympse Bio. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Multiple human diseases are monitored noninvasively through urine-based analysis.
|
2015 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Sunbird Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sunbird Bio Comparisons
Competitors of Sunbird Bio
Sunbird Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Natera, Foundation Medicine, ArcherDX and Strand Life Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sunbird Bio
Frequently Asked Questions about Sunbird Bio
When was Sunbird Bio founded?
Sunbird Bio was founded in 2020 and raised its 1st funding round 4 years after it was founded.
Where is Sunbird Bio located?
Sunbird Bio is headquartered in Singapore.
Who is the current CEO of Sunbird Bio?
John McDonough is the current CEO of Sunbird Bio.
Is Sunbird Bio a funded company?
Sunbird Bio is a funded company, having raised a total of $14M across 1 funding round to date. The company's 1st funding round was a Series B of $14M, raised on Oct 16, 2024.
What does Sunbird Bio do?
Sunbird Bio was founded in 2020 in Singapore within the biotechnology sector. Diagnostic technologies are developed for detecting infectious diseases, cancer biomarkers, and neurological conditions. The enVision Platform is employed for infectious disease identification and cancer detection. The APEX Platform is utilized to identify protein aggregates linked to neurodegenerative diseases. Operations focus on advancing these platforms for medical diagnostics.
Who are the top competitors of Sunbird Bio?
Sunbird Bio's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.
What products or services does Sunbird Bio offer?
Sunbird Bio offers APEX Test and ELISA Technology.
How many acquisitions has Sunbird Bio made?
Sunbird Bio has made 1 acquisition, including Glympse Bio.
Who are Sunbird Bio's investors?
Sunbird Bio has 5 investors. Key investors include Lilly, EDBI, ClavystBio, Polaris Partners, and S32.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.